Yale-New Haven Medical Center Geriatric Psychiatry

Topics

• Suicide and Self-Harm Studies 160
• Dementia and Cognitive Impairment Research 117
• Alzheimer's disease research and treatments 54
• Mental Health Treatment and Access 36
• Treatment of Major Depression 32
• Schizophrenia research and treatment 31
• Electroconvulsive Therapy Studies 30
• Neurotransmitter Receptor Influence on Behavior 25
• Geriatric Care and Nursing Homes 18
• Health disparities and outcomes 18
• Neuroscience and Neuropharmacology Research 18
• Healthcare professionals’ stress and burnout 17

Most cited

1. Lecanemab in Early Alzheimer's Disease.

   The New England journal of medicine · 2023 · 4,522 citations · Christopher van Dyck

2. Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease.

   The journal of prevention of Alzheimer's disease · 2022 · 1,162 citations · Christopher van Dyck

3. Trial of Solanezumab in Preclinical Alzheimer's Disease.

   The New England journal of medicine · 2023 · 359 citations · Christopher van Dyck

4. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.

   The New England journal of medicine · 2023 · 225 citations · Robert Ostroff

5. Updated safety results from phase 3 lecanemab study in early Alzheimer's disease.

   Alzheimer's research & therapy · 2024 · 162 citations · Christopher van Dyck

6. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.

   Nature medicine · 2021 · 305 citations · Christopher van Dyck

7. Review of Major Social Determinants of Health in Schizophrenia-Spectrum Psychotic Disorders: I. Clinical Outcomes.